These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Accuracy assessment of a potential clinical use of navigation-guided intra-operative liver metastasis brachytherapy-a planning study. Herrmann E; Terribilini D; Manser P; Fix MK; Toporek G; Candinas D; Weber S; Aebersold DM; Loessl K Strahlenther Onkol; 2018 Nov; 194(11):1030-1038. PubMed ID: 30022277 [TBL] [Abstract][Full Text] [Related]
6. A Novel Form of Breast Intraoperative Radiation Therapy With CT-Guided High-Dose-Rate Brachytherapy: Results of a Prospective Phase 1 Clinical Trial. Showalter SL; Petroni G; Trifiletti DM; Libby B; Schroen AT; Brenin DR; Dalal P; Smolkin M; Reardon KA; Showalter TN Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):46-54. PubMed ID: 27511846 [TBL] [Abstract][Full Text] [Related]
7. 3D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma. Ren Y; Zhao Q; Liu H; Huang Y; Wang Z; Cao X; Teh BS; Wen B BMC Cancer; 2014 Nov; 14():894. PubMed ID: 25432818 [TBL] [Abstract][Full Text] [Related]
8. Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma. Schnapauff D; Denecke T; Grieser C; Collettini F; Seehofer D; Sinn M; Banzer J; Lopez-Hänninen E; Hamm B; Wust P; Gebauer B Cardiovasc Intervent Radiol; 2012 Jun; 35(3):581-7. PubMed ID: 21833806 [TBL] [Abstract][Full Text] [Related]
9. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer. Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929 [TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted MRI (DWI) for assessment of response to high-dose-rate CT-guided brachytherapy (HDR-BT) of hepatocellular carcinoma. Karim H; Thormann M; Omari J; Surov A; Schinner R; Seidensticker R; Ingenerf M; Ricke J; Schmid-Tannwald C Acta Radiol; 2024 Jan; 65(1):14-22. PubMed ID: 36843430 [TBL] [Abstract][Full Text] [Related]
11. Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial. Xiang L; Zhang JW; Lin S; Luo HQ; Wen QL; He LJ; Shang CL; Ren PR; Yang HR; Pang HW; Yang B; He HL; Chen Y; Wu JB Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1027-1034. PubMed ID: 26194678 [TBL] [Abstract][Full Text] [Related]
12. Fractionated intraluminal HDR 192Ir brachytherapy as palliative treatment in patients with endobronchial metastases from non-bronchogenic primaries. Stranzl H; Gabor S; Mayer R; Prettenhofer U; Wurzinger G; Hackl A Strahlenther Onkol; 2002 Aug; 178(8):442-5. PubMed ID: 12240550 [TBL] [Abstract][Full Text] [Related]
14. Computed Tomography-Planned High-Dose-Rate Brachytherapy for Treating Uterine Cervical Cancer. Zolciak-Siwinska A; Gruszczynska E; Bijok M; Jonska-Gmyrek J; Dabkowski M; Staniaszek J; Michalski W; Kowalczyk A; Milanowska K Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):87-92. PubMed ID: 27375169 [TBL] [Abstract][Full Text] [Related]
15. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. Ricke J; Wust P; Wieners G; Beck A; Cho CH; Seidensticker M; Pech M; Werk M; Rosner C; Hänninen EL; Freund T; Felix R J Vasc Interv Radiol; 2004 Nov; 15(11):1279-86. PubMed ID: 15525748 [TBL] [Abstract][Full Text] [Related]
16. Radioablation of Hepatic Metastases from Renal Cell Carcinoma With Image-guided Interstitial Brachytherapy. Omari J; Heinze C; Damm R; Hass P; Janitzky A; Wendler JJ; Seidensticker M; Ricke J; Powerski MJ; Pech M Anticancer Res; 2019 May; 39(5):2501-2508. PubMed ID: 31092445 [TBL] [Abstract][Full Text] [Related]
17. Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix. Kamran SC; Manuel MM; Cho LP; Damato AL; Schmidt EJ; Tempany C; Cormack RA; Viswanathan AN Gynecol Oncol; 2017 May; 145(2):284-290. PubMed ID: 28318644 [TBL] [Abstract][Full Text] [Related]
18. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma? Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850 [TBL] [Abstract][Full Text] [Related]
19. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival. Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348 [TBL] [Abstract][Full Text] [Related]
20. Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786). Vigneault E; Morton G; Parulekar WR; Niazi TM; Springer CW; Barkati M; Chung P; Koll W; Kamran A; Monreal M; Ding K; Loblaw A Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):527-533. PubMed ID: 29903505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]